Financial Statements — EVMN
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q3 2025 |
|---|---|---|---|
| Cash & Equivalents | 60.03 | 48.32 | 26.82 |
| Short-term Investments | 140.76 | 163.15 | 49.24 |
| Total Current Assets | 204.25 | 215.86 | 81.94 |
| Property, Plant & Equipment | 1.65 | 1.64 | 0.97 |
| Total Non-current Assets* | 97.70 | 106.60 | 2.60 |
| Total Assets | 301.95 | 322.46 | 84.54 |
| Accounts Payable | 5.04 | 4.05 | 3.58 |
| Total Current Liabilities | 17.49 | 10.60 | 10.42 |
| Total Non-current Liabilities* | 6.87 | 7.30 | 0.26 |
| Total Liabilities | 24.36 | 17.90 | 10.68 |
| Retained Earnings | (275.01) | (242.76) | (192.82) |
| Total Stockholder Equity | 277.59 | 304.56 | (183.14) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 10.00 |
| Research & Development | 26.41 | 17.32 | 20.40 | 19.64 |
| Selling, General & Admin | 8.48 | 6.64 | 9.31 | 3.69 |
| Total Operating Expenses | 34.90 | 23.95 | 29.72 | 23.33 |
| Operating Income | (34.90) | (23.95) | (29.72) | (13.33) |
| Pretax Income* | (32.25) | (21.67) | (28.27) | (12.47) |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | (32.25) | (21.67) | (28.27) | (12.47) |
| Basic EPS | (0.89) | (0.64) | 15.14 | (8.07) |
| Diluted EPS | (0.89) | (0.64) | 15.14 | (8.07) |
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Operating Cash Flow | (20.32) | (27.50) | (16.70) | (59.74) |
| Capital Expenditures | 0.18 | 0.08 | 0.10 | 0.13 |
| Free Cash Flow* | (20.50) | (27.59) | (16.80) | (59.87) |
| Investing Cash Flow | 31.29 | (85.36) | (122.90) | 7.59 |
| Financing Cash Flow | 0.53 | 117.11 | 156.85 | 63.92 |
* Derived from reported values